On February 6, 2019, Nelson Obus– Director of Landec Corp. LNDC – purchased 20,000 shares at $12.38 through is fund – Wynnefield Capital, Inc. – at a total cost of $247,600.
If you found this post helpful, please consider visiting a few of our sponsors who have offers that may be relevant to you.
On February 5, 2019, Paul Klauder – Executive Vice President of SEI Investments Co. SEIC – purchased 3,110 shares at $49.81 for an out of pocket cost of $159,909.
If you found this post helpful, please consider visiting a few of our sponsors who have offers that may be relevant to you.
On January 31, 2019, John Stratton – a Director of Abbott Laboratories ABT – purchased 3,455 shares at $72.32 for an out of pocket cost of $249,875.
If you found this post helpful, please consider visiting a few of our sponsors who have offers that may be relevant to you.
Alexander Denner – a Director of Biogen BIIB, purchased 62,800 shares of stock last week through his fund Sarissa Capital Management, LP. This was a $20,572,407 purchase.
On 1/28/19, Huntley Garriott – the President of Live Oak Bankshares, Inc. (LOB) – purchased 20,000 shares of stock at $13.82 for a total out of pocket purchase of $276,400. Other insiders added ~$127,000 of purchases in the same 24 hour period.
If you found this post helpful, please consider visiting a few of our sponsors who have offers that may be relevant to you.
Yesterday, Richard Kinder – Executive Chairman of Kinder Morgan KMI – purchased 65,260 shares of his company’s stock at $17.95/share for a total out of pocket cost of $1,171,410. This is on top of $8,776,500 he purchased Continue reading “Insider Buying”
Director Michael Schmertzler purchased $1,999,995 (66,225 shares) of PTC Therapeutics, inc. PTCT stock through his fund Sections Six Partners, LP on 1/25/2019. The stock was down ~40% off of its Oct 1 peak at purchase.
If you found this post helpful, consider visiting a few of our sponsors who have offers that may be relevant to you.
Yesterday 1/28/19, Francis Blake – a Director of DAL (Delta Airlines) – purchased 5,185 shares of stock at $48.17 for a total out of pocket purchase of $249,743.
If you found this post helpful, please consider visiting a few of our sponsors who have offers that may be relevant to you.
Last week, 3 Directors of small biotech BLPH – Bellerophon Theraputics, Inc bought a combined $1,215,000 worth of stock with their own money. This is the first such purchase that any of these 3 directors bought stock in the open market.
If you found this post helpful, consider visiting a few of our sponsors who have offers that may be relevant to you.
This week, James DeFranco (Executive VP) at DISH (Dish Network) purchased 25,000 shares in the open market at $28.01 with his own money. It is a $700,350 vote of confidence he is making in the company.
If you found this post helpful, consider visiting a few of our sponsors who have offers that may be relevant to you.
